Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2023-06-30 (2 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE REVEST-LES-EAUX (83200), Var
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DU REVEST : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU REVEST is a French company
founded 2 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE REVEST-LES-EAUX (83200),
this company of category PME
shows in 2025 a net income positive of 24 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU REVEST (SIREN 953999638)
Indicator
2025
2024
Revenue
N/C
N/C
Net income
24 391 €
-166 914 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE DU REVEST generates positive net income of 24 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
24 391 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -1039%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -9%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-1039.462%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-9.388%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU REVEST
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2024
2025
Debt ratio
-922.86
-1039.462
Financial autonomy
-10.528
-9.388
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
-1039.462025
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent
In 2025, the debt ratio of SELARL PHARMACIE DU REVEST (-1039.46) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-9.39%2025
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch
In 2025, the financial autonomy of SELARL PHARMACIE DU REVEST (-9.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 220.39. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
220.386
Liquidity indicators evolution SELARL PHARMACIE DU REVEST
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2024
2025
Liquidity ratio
165.111
220.386
Interest coverage
None
None
Sector positioning
Liquidity ratio
220.392025
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+21 pts over 2 years
In 2025, the liquidity ratio of SELARL PHARMACIE DU REVEST (220.39) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELARL PHARMACIE DU REVEST in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DU REVEST is estimated at
387 453 €
(range 262 928€ - 607 968€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
262k€387k€607k€
387 453 €Range: 262 928€ - 607 968€
NAF 5 année 2025
Valuation method used
Net Income Multiple
24 391 €
×
15.9x
=387 454 €
Range: 262 928€ - 607 969€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU REVEST with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU REVEST
What is the revenue of SELARL PHARMACIE DU REVEST ?
The revenue of SELARL PHARMACIE DU REVEST is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DU REVEST profitable?
Yes, SELARL PHARMACIE DU REVEST generated a net profit of 24 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DU REVEST ?
The headquarters of SELARL PHARMACIE DU REVEST is located in LE REVEST-LES-EAUX (83200), in the department Var.
Where to find the tax return of SELARL PHARMACIE DU REVEST ?
The tax return of SELARL PHARMACIE DU REVEST is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU REVEST operate?
SELARL PHARMACIE DU REVEST operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart